RxDoctor Payments Data

Marissa Morningstar Tenenbaum, MD

Plastic and Reconstructive Surgery · Saint Louis, MONPI 1124232236

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,328 of the $28,244 with a category attached, or 79.1%. Surgalign Spine Technologies, Inc. accounts for 65.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $19,659 and has fallen 82.3% since, to $3,477 in 2025.

$28,244in general payments, 2019–2025

Across 83 payments — averaging $340.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgalign Spine Technologies, Inc.$19K
  • Motiva USA, LLC$3K
  • RTI Surgical, Inc$2K
  • AbbVie$2K
  • Merz North America, Inc.$770
  • Tepha Inc$365
  • plus $978 from 8 others
$265,333in research payments, 2019–2025

Across 278 payments — averaging $954.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$251K
  • Medical Device Business Services, Inc.$15K

What the payments were for

  • Consulting fees$22,32879%
  • Travel & lodging$1,7666%
  • Food & beverage$4,06414%
  • Gifts$870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,244 in reported general payments places this provider in the 85th percentile of 61 plastic and reconstructive surgery providers in Missouri.

See all plastic and reconstructive surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$24,315
Medicare patients
34
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib19$420
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$124
Doxycycline Hyclate13$117
Cyclobenzaprine Hcl14$114
Pregabalin12$58
Ondansetron OdtOndansetron17$15

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →